<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d51">
    <sentence id="DDI-DrugBank.d51.s0" text="ATROVENT Inhalation Aerosol has been used concomitantly with other drugs, including sympathomimetic bronchodilators, methylxanthines, and steroids, commonly used in the treatment of chronic obstructive pulmonary disease.">
        <entity charOffset="0-7" id="DDI-DrugBank.d51.s0.e0" text="ATROVENT" type="brand"/>
        <entity charOffset="84-114" id="DDI-DrugBank.d51.s0.e1" text="sympathomimetic bronchodilators" type="group"/>
        <entity charOffset="117-131" id="DDI-DrugBank.d51.s0.e2" text="methylxanthines" type="group"/>
        <entity charOffset="138-145" id="DDI-DrugBank.d51.s0.e3" text="steroids" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s0.e0" e2="DDI-DrugBank.d51.s0.e1" id="DDI-DrugBank.d51.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s0.e0" e2="DDI-DrugBank.d51.s0.e2" id="DDI-DrugBank.d51.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s0.e0" e2="DDI-DrugBank.d51.s0.e3" id="DDI-DrugBank.d51.s0.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s0.e1" e2="DDI-DrugBank.d51.s0.e2" id="DDI-DrugBank.d51.s0.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s0.e1" e2="DDI-DrugBank.d51.s0.e3" id="DDI-DrugBank.d51.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s0.e2" e2="DDI-DrugBank.d51.s0.e3" id="DDI-DrugBank.d51.s0.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d51.s1" text="With the exception of albuterol, there are no formal studies fully evaluating the interaction effects of ATROVENT Inhalation Aerosol and these drugs with respect to effectiveness.">
        <entity charOffset="22-30" id="DDI-DrugBank.d51.s1.e0" text="albuterol" type="drug"/>
        <entity charOffset="105-112" id="DDI-DrugBank.d51.s1.e1" text="ATROVENT" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s1.e0" e2="DDI-DrugBank.d51.s1.e1" id="DDI-DrugBank.d51.s1.p0"/>
    <negationtags>With the exception of albuterol, there are &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; formal studies fully evaluating the interaction effects of ATROVENT Inhalation Aerosol and these drugs with respect to effectiveness. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d51.s2" text="Anticholinergic agents: Although ipratropium bromide is minimally absorbed into the systemic circulation, there is some potential for an additive interaction with concomitantly used anticholinergic medications.">
        <entity charOffset="0-21" id="DDI-DrugBank.d51.s2.e0" text="Anticholinergic agents" type="group"/>
        <entity charOffset="33-51" id="DDI-DrugBank.d51.s2.e1" text="ipratropium bromide" type="drug"/>
        <entity charOffset="182-208" id="DDI-DrugBank.d51.s2.e2" text="anticholinergic medications" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s2.e0" e2="DDI-DrugBank.d51.s2.e1" id="DDI-DrugBank.d51.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d51.s2.e0" e2="DDI-DrugBank.d51.s2.e2" id="DDI-DrugBank.d51.s2.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d51.s2.e1" e2="DDI-DrugBank.d51.s2.e2" id="DDI-DrugBank.d51.s2.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d51.s3" text="Caution is therefore advised in the coadministration of ATROVENT Inhalation Aerosol with other anticholinergic-containing drugs.">
        <entity charOffset="56-63" id="DDI-DrugBank.d51.s3.e0" text="ATROVENT" type="brand"/>
        <entity charOffset="95-109" id="DDI-DrugBank.d51.s3.e1" text="anticholinergic" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d51.s3.e0" e2="DDI-DrugBank.d51.s3.e1" id="DDI-DrugBank.d51.s3.p0" type="advise"/>
    </sentence>
</document>